PORTAGE,
Mich., March 6, 2025 /PRNewswire/ -- Inari
Medical, now part of Stryker (NYSE: SYK), a global leader in
medical technologies, announced the launch of its Artix
Thrombectomy System. Purpose-built for the distinct needs of the
peripheral arterial system, Artix is a combined aspiration plus
mechanical thrombectomy solution that delivers procedural control
and versatility, and is designed to set a new standard for arterial
thrombectomy.
An arterial blood clot in the leg is a life- and
limb-threatening emergency requiring immediate treatment. However,
existing therapies for arterial thromboembolism can lead to:
- Ineffective clot retrieval leading to additional procedures
(open surgery or amputation1,2)
- Significant blood loss1
- Adverse events such as arterial embolization and vessel
trauma2,3
- High rates of lytic use, which may result in
complications1,2
The Artix System builds on the success of Inari's venous
thrombectomy devices and is its inaugural entry into the arterial
space. Inari offers a comprehensive toolkit approach to arterial
thrombectomy with an innovative, over-the-wire system that provides
physicians with the flexibility to aspirate and/or mechanically
extract a clot.
Jonathan Bowman, MD FACS, Chief
of Vascular at Norwalk Hospital in Norwalk, CT, performed the first commercial
case with Artix on October 19, 2024.
"The Artix Thrombectomy System marks a significant advancement in
peripheral arterial thromboembolism treatment," said Dr. Bowman.
"With Artix, I finally have a solution that effectively addresses a
wide range of clots while enabling me to maintain vessel access and
retain control throughout the entire case. I expect Artix will take
the place of open surgical repair in many of my arterial
cases."
Key distinctive features of the Artix system include:
- Dual mechanical thrombectomy and aspiration toolkit
designed to remove acute to chronic clots in a single session via a
streamlined procedure4
- Aspiration-capable, 8 Fr. low profile, trackable,
kink-resistant sheath in both 65cm and 90cm lengths expands
treatment options by enabling more complex and distal
interventions
- Innovative over-the-wire mechanical element designed to
effectively collect and retrieve acute-to-chronic
clot4
- Covered nitinol mesh funnel provides temporary flow
restriction during the procedure to minimize the risk of arterial
clot migration5
"There is a real clinical need to address chronic thrombi and
decrease the risk of clot migration. Artix will raise the bar of
effective arterial thrombectomy," said Tom
Tu, MD, Chief Medical Officer of Inari Medical. "We are
excited to bring Inari's core competency in thrombectomy to the
arterial space with the goal of improving outcomes."
For more information, visit
https://www.inarimedical.com/artix-system
About Stryker
Stryker is a global leader in medical
technologies and, together with our customers, we are driven to
make healthcare better. We offer innovative products and services
in MedSurg, Neurotechnology and Orthopaedics that help improve
patient and healthcare outcomes. Alongside our customers around the
world, we impact more than 150 million patients annually. More
information is available at www.stryker.com.
On February 19, 2025, Stryker
acquired Inari Medical, a medical device company with a mission to
treat and transform the lives of patients suffering from venous and
other diseases.
Media contact:
Sherri Oakson
Senior Director, Communications
MedSurg and Neurotechnology
sherri.oakson@stryker.com
- De Donato et al. The INDIAN Trial. Eur J Vasc Endovasc
Surg. 2021; 61: 820-828.
- Heller et al. Percutaneous Mechanical Thrombectomy Using
Rotarex Device in Acute Limb Ischemia in Infrainguinal Occlusions.
BioMed Research International. 2017.
- Olinic et al. Acute Limb Ischemia: An Update on Diagnosis and
Management. J Clin Med. 2019.
- Designed to remove acute to chronic arterial clots. According
to benchtop testing compared to control. Internal data on
file. Narula et al. JACC 2018;72:2153-63
- According to benchtop testing compared to control.
Internal data on file. NOTE: To attempt to minimize risk of
arterial embolization of blood clots, use of a device that entraps
clots may potentially be helpful, but this has not yet been
demonstrated to be effective in the arterial system.
Dr. Jonathan Bowman is a paid
consultant of Inari Medical. All views and opinions expressed here
by Dr. Jonathan Bowman are his own
and do not represent those of Inari Medical.
Indications for Use: The Artix thin-walled sheath is
indicated for: (1) The non-surgical removal of emboli
and thrombi from blood vessels. (2) Injection, infusion and/or
aspiration of contrast media and other fluids into or from a blood
vessel. (3) Use as a conduit for endovascular devices. (4) Use in
facilitating the insertion and guidance of an intravascular
catheter into a selected blood vessel. The funnel provides
temporary vascular occlusion during these and other angiographic
procedures. The Artix thin-walled sheath is intended for use in the
peripheral vasculature. The Artix MT thrombectomy device is
indicated for (1) the non-surgical removal of emboli and thrombi
from a blood vessel; and (2) injection, infusion, and/or aspiration
of contrast media and other fluids into or from a blood vessel. The
Artix MT thrombectomy device is intended for use in the peripheral
vasculature. The Artix AX aspiration catheter is indicated for (1)
the non-surgical removal of emboli and thrombi from blood vessels;
and (2) injection, infusion, and/or aspiration of contrast media
and other fluids into or from a blood vessel. The Artix AX
aspiration catheter is intended for use in the peripheral
vasculature. The FlowSaver blood return system is used with Inari
Medical catheters and sheaths for autologous blood transfusion.
Review complete Instructions for Use, Indications for Use,
Warnings, Precautions, Possible Adverse Effects and
Contraindications prior to use of these products.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/inari-medical-now-part-of-stryker-launches-artix-thrombectomy-system-designed-to-address-a-broad-spectrum-of-arterial-thrombus-cases-302394987.html
SOURCE Stryker